Oxygen Infusion and Psoriasis: Case Report

Dr. Domenico Amuso, Dr. Antonella Battista. Thanks for the help of Dr. Andrea Conti.

Psoriasis is a pathology which affects an average of 3% of the general population.

Juvenile psoriasis appears at around twenty years of age and its adult form around fifty years of age. In Italy, 1.7 million cases have been estimated. Prevalence: 3% of the population, with significant worsening of the quality of life, 75% of patients become sick before turning, 15-20% develop a “moderate-serious” form of psoriasis, 10-25% of the cases develop Psoriatic arthritis.

Psoriasis appears often in association with other metabolic illnesses, such as diabetes, obesity, hypertension, dyslipidemia, etc..

All therapies are symptomatic, often cosmetically unacceptable and often toxic. In more than 1/4 of the cases, many clinical “needs” aren’t satisfied.

Whilst treating patients for aesthetical and aging problems with oxygen infusion, we noticed that some of those affected by psoriasis were clinically improving—the crusts on the lesions were losing their characteristic clinical aspect.

We asked for the assistance of a clinical dermatologist and for the consent of some patients affected by moderate/serious psoriasis to be treated with oxygen infusion.

The work protocol adopted was: two sessions a week; each area affected by lesions was treated for no less than eight minutes; patients were treated for a minimum of 12 weeks. All patients accepted treatment voluntarily. The patients treated, in case of a non-effectiveness of the treatment, were scheduled to undergo classical therapies with the dermatologist.

Obviously, we do not mean for oxygen infusion to substitute the fundamental and necessary classical therapies, but since it has no counter-indications and given its excellent properties as a carrier of substances, we propose it as an important co-adjuvant for all those forms of psoriasis presenting comorbidity.